• Kairos Pharma will participate in the Discovery on Target Drug Discovery Conference in Boston from Sept. 28 to Oct. 1.
• Neil Bhowmick will moderate an in-person breakout, “Winning the Race against Cancer Therapy Resistance,” on Sept. 30.
• Bhowmick will deliver a Sept. 30 main-stage presentation on KROS-101, a GITR-targeting candidate for solid tumors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609230800BIZWIRE_USPR_____20260923_BW762234) on September 23, 2026, and is solely responsible for the information contained therein.